News & Events

Calendar of Events

Upcoming seminar and event information

Dr. Robert Harrington

An American Heart Association (AHA) Presidential Advisory, co-authored by a committee including the dean of Weill Cornell Medicine, outlines an ambitious plan to increase rigorous research on initiatives aimed at providing food as medicine for chronic conditions.

 Food is Medicine (FIM) is an increasingly popular approach to help treat or prevent chronic conditions by assisting patients to access healthier food...

Read More
Weill Cornell Medical College

Video of Weill Cornell Medicine Celebrates 125 Years: A Look Back

Weill Cornell Medicine has been at the forefront of medical education since its inception, with a steadfast commitment to providing the best training for generations of physicians.

Founded in 1898, the institution—known at the time as Cornell University Medical College—sought to provide students with the opportunity to be more...

Read More
Composite image of two physicians. The headshot of a woman physician wearing a lab coat on the left, and a photo of a male physician wearing a suit on the right.

Dr. Lisa Newman, chief of the section of breast surgery at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, and Dr. Jedd D. Wolchok, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell...

Read More
Dr. Bishoy Faltas

A Weill Cornell Medicine researcher has received a $610,000 grant from the Department of Defense to investigate the mechanisms causing DNA instability that potentially drives metastasis in bladder cancer. The research also aims to identify methods to intercept this spread. The Peer-Reviewed Cancer Research Program (PRCRP) Idea Award funds innovative, high-risk, high-reward basic cancer research. One of the goals of the PRCRP program is to decrease the burden of cancer on service members and...

Read More
illustration of DNA

Dr. Chenxu Zhu, an assistant professor of physiology and biophysics at Weill Cornell Medicine and a core faculty member of the New York Genome Center, has been awarded the National Institutes of Health Director’s New Innovator Award to fund an ambitious project to develop single-cell sequencing tools, known collectively as “multi-omics,” that...

Read More
Samie Jaffrey

Researchers at Weill Cornell Medicine have illuminated one of the important ways that cells respond to stress. The findings could also be relevant to Alzheimer’s, ALS and other diseases in which this mechanism may be abnormally active.

When stressed by heat, toxins or other potentially damaging factors, cells gather many of their messenger RNAs (mRNAs), molecules that carry the instructions for making proteins, into droplet-like compartments called stress granules. These granules...

Read More
nanofibers targeting lung metastases

Dr. Vanessa Bellat, an assistant professor of chemistry in radiology and an affiliate of the Molecular Imaging Innovations Institute (MI3) at Weill Cornell Medicine, has been awarded a $2 million, four-year R37 MERIT grant from the National Cancer Institute, part of the National Institutes of...

Read More
dendritic cells and T cells

Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two types of immunotherapy—one that boosts T cells, and another that boosts dendritic cells—can control tumors in preclinical models of triple negative breast cancer, a cancer type that’s typically resistant to immunotherapy alone. Immunotherapy activates the body’s own immune system to fight cancer but isn’t effective for difficult-...

Read More
image of man and woman holding hands in the sunlight

Weill Cornell Medicine has received a three-year, nearly $6 million grant to lead one of three national contraceptive research centers. The grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health, will fund the Weill Cornell Medicine Contraception Development Research Center. Led by Drs. Jochen Buck and...

Read More
Generative AI illustration of a skull

Craniosynostosis, the premature fusion of the top of the skull in infants, is caused by an abnormal excess of a previously unknown type of bone-forming stem cell, according to a preclinical study led by researchers at Weill Cornell Medicine.

Craniosynostosis arises from one of several possible gene mutations, and occurs in about one in 2,500 babies. By constricting brain growth, it can lead to abnormal brain development if not corrected surgically. In complex cases, multiple surgeries...

Read More
avatars at a party

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the United States Department of Health and Human Services through the Office of Population Affairs under the Teen Pregnancy Prevention Program to conduct a randomized trial testing whether a bilingual video game called “No Baby No (No Bebé No)” can increase the use of contraception among sexually active Black and Hispanic adolescents.

“Nine out of ten teens play video games. No Baby No empowers Black and...

Read More
green and red labeled cells in immunofluorescent image

The vertebral bones that form the spine are derived from a distinct type of stem cell that secretes a protein favoring tumor metastases, according to a study led by researchers at Weill Cornell Medicine. The discovery opens up a new line of research on spinal disorders, helps explain why solid tumors so often spread to the spine, and could lead to new orthopedic and cancer treatments.

In the study, published Sept. 13 in...

Read More
Colorful awareness ribbon with group of people with rare diseases, using the colors associated with Rare Disease Da

Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center have together been named a Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD). The designation adds the academic medical center to NORD’s collaborative network of 40 participating institutions that research and treat rare diseases.

“We are incredibly proud of...

Read More
An African American woman holding her baby.

As part of a National Institutes of Health initiative to improve maternal health and pregnancy outcomes nationwide, Weill Cornell Medicine and NewYork-Presbyterian will play a pivotal role as collaborators with Columbia University Irving Medical Center (CUIMC) as one of 10 nationwide IMPROVE (Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone)...

Read More
diagram showing how BK-channel blockers access the side of the channel

Ion channels are attractive drug targets due to their importance in health and disease, but finding ways to target a specific ion channel selectively is a major challenge. Now, researchers at Weill Cornell Medicine and RMIT University in Australia have discovered that ion channels called BK channels have unique openings in their sides, which drug molecules may be able to access. The...

Read More
top panels show tetrameric and pentameric forms of ion channel using atomic force microscopy. Lower panel shows cryo-em of the same structures

A member of an important class of ion channel proteins can transiently rearrange itself into a larger structure with dramatically altered properties, according to a study led by researchers at Weill Cornell Medicine. The discovery is a significant advance in cell biology, likely solves a long-standing mystery about an unusual feature of some ion channels and has implications for the development of drugs targeting these proteins and for drug delivery.

Ion channels are ubiquitous in the...

Read More
illustration of a transparent body with an orange stomach and a red tumor in it

An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, extended survival for patients with advanced gastric or gastroesophageal junction cancer that overexpressed a specific biomarker.

Results from the GLOW study, published July 31 in Nature Medicine, together...

Read More
Multi-colored circle with an outer ring, and red and blue lines in the center.

A study led by researchers at Memorial Sloan Kettering Cancer Center (MSK) and Weill Cornell Medicine discovered a new relationship between cancer cells and the immune system, and shows how cancer can selfishly hijack a normally helpful immune pathway.

Read More
illustration of tree with black infestation spreading and orange fruit

Severe COVID-19 infection triggers changes that affect gene expression in immune system stem cells, causing long-lasting alterations in the body’s immune response, according to a new study by Weill Cornell Medicine and Jackson Laboratory investigators. The finding could help explain symptoms of prolonged inflammation and “long COVID” in people who have had the disease.

The research team, led by...

Read More
Students wearing short white coats sitting in rows of seats in an auditorium.

Video of Class of 2027 White Coat Ceremony Highlights | Weill Cornell Medicine

Watch the full Class of 2027 White Coat Ceremony on YouTube.

Nick Rosenfeld’s passion for medicine is profoundly personal, as is his desire for cultivating enduring relationships with patients...

Read More

Government & Community Affairs 1300 York Ave., Box 314 New York, NY 10065